抗CD20（Rituximab）嵌合抗體 | Anti-CD20 (Rituximab), Chimeric Antibody貨號A1049-100
| 代理廠牌： |  |
| 原廠連結： | |
| 相關下載： |
抗CD20（利妥昔單抗）嵌合抗體 | 貨號A1049-100
Anti-CD20 (Rituximab), Chimeric Antibody
BioVision的研究級生物仿製藥。基於人IgG的單克隆抗體（mAb）是癌症治療中增長最快的類別。 幾種單克隆抗體已被FDA批准用於治療各種solid tumors實體瘤和hematological malignancies血液惡性腫瘤。 BioVision提供人IgG型式之的research grade biosimilars 研究級生物仿製藥以供應研究需求。 單克隆抗體使用具有來自治療性抗體的可變區的重組技術製造，以實現相似的安全性和功效。 這些抗體可用作臨床前鑑定之對照和用於開發新型治療劑之效力測定。主要特徵：無添加劑：在含有防腐劑的PBS緩衝液（0.02％Proclin 300）; 高純度：使用蛋白A> 98％純度; 多功能：可用於各種應用; ELISA，Neutralization，流式細胞術，IHC，IF
Immunofluorescent and Immunohistochemical staining using anti-Carcinoembryonic antigen (Arcitumomab), Human IgG1 Antibody (Cat. No. A1096-200) (A & B) and Anti-CD52 (Campath-1H), Human IgG1 Antibody (Cat. No. A1105-200) (C & D).
Rituximab產品介紹: Rituximab利妥昔單抗，一種靶向pan-B細胞標誌物CD20的嵌合單克隆抗體 已被證明被利妥昔單抗與CD20結合激活的細胞破壞機制，包括凋亡的直接信號轉導，補體激活和抗體依賴性細胞毒性。 Rituximab利妥昔單抗應用於治療各種B細胞惡性腫瘤。
更多抗體 抗CD20（利妥昔單抗） | 抗α5β1整合素（Volociximab） | Anti-HER2 (Trastuzumab) | 抗VEGF（Bevacizumab） | 抗EGFR（西妥昔單抗）嵌合抗體 | 抗CD11a（Efalizumab)） | Anti-PD-L1 (Atezolizumab)
| Cat # +Size | A1049-100 |
| Size | 100 µg |
| Antibody Target | CD20 |
| Alternate Name | MabThra |
| Host | Human/Mouse chimeric |
| Antibody Type | Monoclonal |
| Isotype | Human IgG1 |
| Immunogen | CD20 |
| Accession # | NP_690605 |
| Gene ID | 54474 |
| Appearance | Colourless liquid |
| Formulation | In Phosphate buffered saline, pH 7.4. |
| Purification | Protein A chromatography. |
| Species Reactivity | Human |
| Application | Neutralization, ELISA |
| Application & Usage | Neutralization: 1-20 μg/ml; ELISA: 2μg/ml |
| Cat. No. | Product Name | Trade Name | Isotype | Size |
| A1045-100 | Anti-VEGF (Bevacizumab), humanized Antibody | Avastin | Human IgG1 | 100 µg |
| A1046-100 | Anti-HER2 (Trastuzumab), humanized Antibody | Herceptin | Human IgG1 | 100 µg |
| A1047-100 | Anti-EGFR (Cetuximab), Chimeric Antibody | Erbitux | Human IgG1 | 100 µg |
| A1048-100 | Anti-TNF-α (Adalimumab), humanized Antibody | Humira | Human IgG1 | 100 µg |
| A1049-100 | Anti-CD20 (Rituximab), Chimeric Antibody | Mabthera | Human IgG1 | 100 µg |
| A1050-100 | Anti-EGFR (Panitumumab), humanized Antibody | Vectibix | Human IgG1 | 100 µg |
| A1088-200 | Anti-OX40L (Oxelumab), Human IgG1 Antibody | Xolair | Human IgG1 | 200 µg |
| A1089-200 | Anti-CD11a (Efalizumab), Human IgG1 Antibody | Raptiva | Human IgG1 | 200 µg |
| A1090-200 | Anti-EGFR (Matuzumab), Human IgG1 Antibody | Matuzumab | Human IgG1 | 200 µg |
| A1091-200 | Anti-CD4 (Clenoliximab), Human IgG4 Antibody | Clenoliximab | Human IgG4 | 200 µg |
| A1092-200 | Anti-alpha 5 beta 1 Integrin (Volociximab), Human IgG4 Antibody | Volociximab | Human IgG4 | 200 µg |
| A1093-200 | Anti-TNF alpha (Humicade), Human IgG4 Antibody | Humicade | Human IgG4 | 200 µg |
| A1094-200 | Anti-CD40L (Ruplizumab), Human IgG1 Antibody | Antova | Human IgG1 | 200 µg |
| A1096-200 | Anti-Carcinoembryonic antigen (Arcitumomab), Human IgG1 Antibody | CEA-Scan | Human IgG1 | 200 µg |
| A1097-200 | Anti-TNF alpha (Infliximab), Human IgG1 Antibody | Remicade | Human IgG1 | 200 µg |
| A1098-200 | Anti-IL-2R alpha (CD25) (Basiliximab), Human IgG1 Antibody | Simulect | Human IgG1 | 200 µg |
| A1099-200 | Anti-IL-2R alpha (Daclizumab), Human IgG1 Antibody | Zenapax | Human IgG1 | 200 µg |
| A1105-200 | Anti-CD52 (Campath-1H), Human IgG1 Antibody | Campath | Human IgG1 | 200 µg |
| A1305-100 | Anti-PD-L1 (Atezolizumab), Humanized Antibody | Tecentriq | Human IgG1 | 100 µg |
| A1306-100 | Anti-PD-1 (Pembrolizumab), Humanized Antibody | Keytruda | Human IgG1 | 100 µg |
| A1307-100 | Anti-PD-1 (Nivolumab), Humanized Antibody | Opdivo | Human IgG1 | 100 µg |
蛋白質定量商品 Coomassie blue蛋白質定量分析套組 | BCA蛋白測定試劑盒(低濃度10-600ug/ml)| 5％耐洗滌 | BCA蛋白測定試劑盒 (還原劑兼容)